Jai Pharma Limited - Company Profile

It is a healthcare public limited company based in Mumbai, Maharashtra, India, established in 2015.
2015 Mumbai, Maharashtra, India Amalgamated
Last Updated:
Access Report
About Jai Pharma Limited

Jai Pharma Limited, a amalgamated public limited company, was established on 18 February 2015 in Mumbai, Maharashtra, India. Engaging in medical consumables & supplies within the healthcare sector, it holds CIN: U74999MH2015PLC262055. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.71 Cr.

Employing 517 professional, Its leadership includes Atul Sud (Additional Director), Sarada Kalyani Bhagawati (Additional Director), Rakesh Bamzai (Additional Director). Past directors included Jyotiprasad Taparia, Sanjeevkumar Taparia, Satishchandra Girdharilal Sharma. It is based at 2Nd Floor, Brady House, 12/14, Veer Nariman Road, Fort, Mumbai, Maharashtra, 400001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2015PLC262055

  • Registration Number

    262055

  • Incorporation Date

    18 February 2015

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹1.71 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 1.71 Cr
  • Company Age 11 Year, 1 Month
Company report

Jai Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Jai Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jai Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Atul Sud Additional Director 20 Nov 2015 Current
Sarada Kalyani Bhagawati Additional Director 20 Nov 2015 Current
Rakesh Bamzai Additional Director 20 Nov 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 20 Nov 2015 Past
Pramod Abcsdd Director 20 Nov 2015 Past
Pramod Abcsdd Director 20 Nov 2015 Past
Pramod Abcsdd Director 24 Nov 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jai Pharma.

Enhance accessibility to Jai Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Jai Pharma revenue growth over time
Jai Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jai Pharma?

Unlock access to Jai Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Jai Pharma?

Jai Pharma has a workforce of 517 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jai Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jai Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jai Pharma
Recent Activity within the Organization
  • Director Appointment

    Atul Sud was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.

  • Director Appointment

    Sarada Kalyani Bhagawati was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Rakesh Bamzai was appointed as a Additional Director was appointed as a Additional Director on 20 Nov 2015 & has been associated with this company since 10 years 4 months . was documented.

  • Company Incorporation

    The activity Jai Pharma Limited was registered on 18 Feb 2015 with Roc Mumbai & aged 11 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jai Pharma Limited?

The CIN of Jai Pharma Limited is U74999MH2015PLC262055.

Where is Jai Pharma Limited headquartered?

Jai Pharma Limited is headquartered at 2Nd Floor, Brady House, 12/14, Veer Nariman Road, Fort, Mumbai, Maharashtra, 400001.

When was Jai Pharma Limited incorporated?

Jai Pharma Limited was incorporated on 18 February 2015.

Who are the current directors of Jai Pharma Limited?

The current directors of Jai Pharma Limited are

What is the primary industry of Jai Pharma Limited?

The primary industry of Jai Pharma Limited is Healthcare.

Is Jai Pharma Limited a listed company?

Jai Pharma Limited is unlisted.

What is the capital structure of Jai Pharma Limited?

The authorized capital of Jai Pharma Limited is ₹2.00 Cr, and the paid-up capital is ₹1.71 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available